ECCRINE SQUAMOUS SYRINGOMETAPLASIA

ECCRINE SQUAMOUS SYRINGOMETAPLASIA was reported 36 times

ECCRINE SQUAMOUS SYRINGOMETAPLASIA is most prevalent among patients taking these drug classes:

# Drug class Count Frequency
0 Antimetabolite Immunosuppressant [EPC] 1 0.0000
1 Progesterone [EPC] 1 0.0000
2 Alkylating Drug [EPC] 6 0.0000
3 Microtubule Inhibitor [EPC] 4 0.0000
4 Calcineurin Inhibitor Immunosuppressant [EPC] 3 0.0000
5 Nucleoside Metabolic Inhibitor [EPC] 5 0.0000
6 Kinase Inhibitor [EPC] 9 0.0000
7 Platinum-based Drug [EPC] 3 0.0000
8 Purine Antimetabolite [EPC] 1 0.0000
9 Estrogen [EPC] 1 0.0000
10 Retinoid [EPC] 1 0.0000
11 Dihydropyridine Calcium Channel Blocker [EPC] 1 0.0000
12 Folate Analog Metabolic Inhibitor [EPC] 1 0.0000
13 Corticosteroid [EPC] 2 0.0000